Search Results
75th Scientific Sessions: Studying Cardiovascular Safety of Type 2 Diabetes Medications
75th Scientific Sessions: Interview with CEO Kevin L. Hagan and Dr. Robert Ratner
75th Scientific Sessions: Who Needs Diabetes Self-Management Education and When?
75th Scientific Sessions: Honoring 50 Years of Diabetes Research and Treatment
Cardiovascular Effects of Drugs to Treat Type II Diabetes Mellitus
75th Scientific Sessions: GLP-1 Alters How the Brain Responds to Food
Know Diabetes by Heart: The American Diabetes Association’s 83rd Scientific Sessions Recap
FDA Opens Safety Review of Diabetes Drugs and More
Novel Diabetes Medications: Questions to Ask Your Doctor
Veselin MITROVIĆ: "Arrhythmias/sudden cardiac death in CAD and HF in type 2 diabetes "
Cardiovascular Outcomes Trials With Anti-Diabetes Medications
GLP-1 Agonists in T2D: Cardiovascular Outcomes Data
